Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis

Molecular classification of bladder carcinoma is a relevant topic in modern bladder cancer oncology due to its potential to improve oncological outcomes. The available molecular classifications are generally based on transcriptomic profiles, generating highly diverse categories with limited correlat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Antonio Lopez-Beltran, Ana Blanca, Alessia Cimadamore, Rajan Gogna, Rodolfo Montironi, Liang Cheng
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/1776742134fa4f18a8f9f619a18e0621
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1776742134fa4f18a8f9f619a18e0621
record_format dspace
spelling oai:doaj.org-article:1776742134fa4f18a8f9f619a18e06212021-11-11T15:33:45ZMolecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis10.3390/cancers132155002072-6694https://doaj.org/article/1776742134fa4f18a8f9f619a18e06212021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5500https://doaj.org/toc/2072-6694Molecular classification of bladder carcinoma is a relevant topic in modern bladder cancer oncology due to its potential to improve oncological outcomes. The available molecular classifications are generally based on transcriptomic profiles, generating highly diverse categories with limited correlation. Implementation of molecular classification in practice is typically limited due to the high complexity of the required technology, the elevated costs, and the limited availability of this technology worldwide. We have conducted a gene expression analysis using a four-gene panel related to luminal and basal subtypes in a series of 91 bladder cancer cases. NanoString-based gene expression analysis using typically luminal (GATA3+/KRT20+) and basal markers (KRT14+/KRT5+/GATA3low/-/KRT20low/-) classified urothelial bladder carcinoma samples as luminal, basal, and a third category (KRT14-/KRT5-/GATA3-/KRT20-), null/double negative (non-luminal/non-basal). These three categories were meaningful in terms of overall cancer-specific survival (<i>p </i>< 0.0001) or when classified as conventional urothelial carcinoma and variant histology urothelial carcinoma (<i>p </i>< 0.0001), NMIBC vs. MIBC (<i>p </i>< 0.001), or by AJCC stage category Ta (<i>p </i>= 0.0012) and T1 (<i>p </i>< 0.0001) but did not reach significance in T2-T4 (<i>p </i>= 0.563). PD-L1 expression (low vs. high) was also different according to molecular subtype, with high PD-L1 expression mostly seen in basal and null subtypes and carcinomas with variant histology (<i>p </i>= 0.002). Additionally, the luminal subtype was enriched in NMIBC with favorable cancer-specific survival (<i>p </i>< 0.0001). In contrast, basal and null subtypes resulted in aggressive MIBC tumors with shorter cancer-specific survival (<i>p </i>< 0.0001), some of which presented variant histology. In conclusion, a comprehensive evaluation of a gene classifier related to molecular taxonomy using NanoString technology is feasible. Therefore, it might represent an accessible and affordable tool in this rapidly expanding area of precision genomics.Antonio Lopez-BeltranAna BlancaAlessia CimadamoreRajan GognaRodolfo MontironiLiang ChengMDPI AGarticlebladder cancermolecular taxonomymolecularclassificationNanoStringluminalNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5500, p 5500 (2021)
institution DOAJ
collection DOAJ
language EN
topic bladder cancer
molecular taxonomy
molecular
classification
NanoString
luminal
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle bladder cancer
molecular taxonomy
molecular
classification
NanoString
luminal
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Antonio Lopez-Beltran
Ana Blanca
Alessia Cimadamore
Rajan Gogna
Rodolfo Montironi
Liang Cheng
Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis
description Molecular classification of bladder carcinoma is a relevant topic in modern bladder cancer oncology due to its potential to improve oncological outcomes. The available molecular classifications are generally based on transcriptomic profiles, generating highly diverse categories with limited correlation. Implementation of molecular classification in practice is typically limited due to the high complexity of the required technology, the elevated costs, and the limited availability of this technology worldwide. We have conducted a gene expression analysis using a four-gene panel related to luminal and basal subtypes in a series of 91 bladder cancer cases. NanoString-based gene expression analysis using typically luminal (GATA3+/KRT20+) and basal markers (KRT14+/KRT5+/GATA3low/-/KRT20low/-) classified urothelial bladder carcinoma samples as luminal, basal, and a third category (KRT14-/KRT5-/GATA3-/KRT20-), null/double negative (non-luminal/non-basal). These three categories were meaningful in terms of overall cancer-specific survival (<i>p </i>< 0.0001) or when classified as conventional urothelial carcinoma and variant histology urothelial carcinoma (<i>p </i>< 0.0001), NMIBC vs. MIBC (<i>p </i>< 0.001), or by AJCC stage category Ta (<i>p </i>= 0.0012) and T1 (<i>p </i>< 0.0001) but did not reach significance in T2-T4 (<i>p </i>= 0.563). PD-L1 expression (low vs. high) was also different according to molecular subtype, with high PD-L1 expression mostly seen in basal and null subtypes and carcinomas with variant histology (<i>p </i>= 0.002). Additionally, the luminal subtype was enriched in NMIBC with favorable cancer-specific survival (<i>p </i>< 0.0001). In contrast, basal and null subtypes resulted in aggressive MIBC tumors with shorter cancer-specific survival (<i>p </i>< 0.0001), some of which presented variant histology. In conclusion, a comprehensive evaluation of a gene classifier related to molecular taxonomy using NanoString technology is feasible. Therefore, it might represent an accessible and affordable tool in this rapidly expanding area of precision genomics.
format article
author Antonio Lopez-Beltran
Ana Blanca
Alessia Cimadamore
Rajan Gogna
Rodolfo Montironi
Liang Cheng
author_facet Antonio Lopez-Beltran
Ana Blanca
Alessia Cimadamore
Rajan Gogna
Rodolfo Montironi
Liang Cheng
author_sort Antonio Lopez-Beltran
title Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis
title_short Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis
title_full Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis
title_fullStr Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis
title_full_unstemmed Molecular Classification of Bladder Urothelial Carcinoma Using NanoString-Based Gene Expression Analysis
title_sort molecular classification of bladder urothelial carcinoma using nanostring-based gene expression analysis
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/1776742134fa4f18a8f9f619a18e0621
work_keys_str_mv AT antoniolopezbeltran molecularclassificationofbladderurothelialcarcinomausingnanostringbasedgeneexpressionanalysis
AT anablanca molecularclassificationofbladderurothelialcarcinomausingnanostringbasedgeneexpressionanalysis
AT alessiacimadamore molecularclassificationofbladderurothelialcarcinomausingnanostringbasedgeneexpressionanalysis
AT rajangogna molecularclassificationofbladderurothelialcarcinomausingnanostringbasedgeneexpressionanalysis
AT rodolfomontironi molecularclassificationofbladderurothelialcarcinomausingnanostringbasedgeneexpressionanalysis
AT liangcheng molecularclassificationofbladderurothelialcarcinomausingnanostringbasedgeneexpressionanalysis
_version_ 1718435163320352768